Seeking Alpha

Bio-researcher Cytokinetics (CYTK) says it's cutting its work force and narrowing its resources...

Bio-researcher Cytokinetics (CYTK) says it's cutting its work force and narrowing its resources to better focus on the development of its heart failure and muscular dysfunction treatments. Shares +1% AH.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)